1 active trials 1 recruiting 2 disease areas
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-08-19 | NCT07774390 Ibrutinib Plus Venetoclax Long-Term Outcomes in CLL | Recruiting |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Not specified | ||||
| NCT07774390 | Ibrutinib Plus Venetoclax Long-Term Outcomes in CLL | Chronic Lymphocytic Leukemia (CLL) | Recruiting | 2026-08-19 |
Leukemia (1) · Chronic Lymphocytic Leukemia (CLL) (1)